The Ontario healthcare system is under strain, still recovering from the demands of the COVID-19 pandemic. The University Health Network (UHN) and Boehringer Ingelheim (Canada) Ltd. have partnered to address a critical need of heart failure patients.
The objective of the partnership is to expand patient reach of UHN’s successful Medly Program— an innovative, digital therapeutic solution that delivers the benefits of specialized clinical heart failure management at home while improving quality of life and reducing hospitalizations.
We are pleased to announce that both TRANSFORM HF’s applicants to the 2022 CIHR Health Systems Impact Fellows (HSI) competition, Sarah Lawrason and Samuel Petrie, were successful!
Darshan Brahmbhatt’s interest in heart failure innovations and remote monitoring led him to become a 2021 TRANSFORM HF Trainee.
As his Trainee Award comes to a close, we sat down with Darshan to talk about his research over the past year and where he sees the field of digital health heading.
In a Canadian population of older ethnic adults living with heart failure, what is the impact of engaging family caregivers in a model of shared virtual care to support technology use and symptom management?
This is the question Dr. Quynh Pham and her team set out to answer as they build Medly Caretown, a family-centered shared virtual care model for patient-caregiver pairs.
Q&A with Health Technology Assessment expert Dr. Val Rac. The value of AI-powered technologies in providing precision tools and insights for both patients and healthcare providers has become widely recognized. As a result, these technologies are becoming more...
